Hollyoaks storyline 'devastating but important'

Hollyoaks is tackling a critical health issue through the storyline of Diane Hutchinson, played by Alex Fletcher, who has been diagnosed with stage four ovarian cancer. The storyline aims to raise awareness about ovarian cancer, a disease often diagnosed late, with over 75% of women receiving an advanced-stage diagnosis. Fletcher, who has portrayed Diane since 2010 and is set to leave the show this year, emphasized the importance of portraying the storyline with accuracy and sensitivity, reflecting the real experiences of those affected. The production collaborated closely with Ovarian Cancer Action to ensure the depiction was both realistic and respectful. Marie-Claire Platt, director of research and policy at the charity, highlighted the potential impact of the storyline in educating viewers and raising awareness, noting that such portrayals can reach audiences more effectively than traditional campaigns. To further support this effort, Fletcher and fellow actress Jessica Fox participated in a documentary titled "Know The Signs. Trust The Signs," where they spoke with women who have lived with ovarian cancer, discussing symptoms, stigmas, and the importance of early detection. The documentary features personal stories from Natasha Reynolds, diagnosed with a rare form of ovarian cancer at 22 after months of misdiagnosis, and Jess Brown, who was diagnosed in 2018 and faced surgical menopause as part of her treatment. Both women stressed the importance of self-awareness and advocating for one’s health, especially given how ovarian cancer symptoms can be subtle and easily overlooked. Their experiences underscore the urgent need for increased research and public understanding of the disease. By integrating this storyline into a popular soap opera, Hollyoaks hopes to reach a broad audience and encourage women to recognize symptoms early and seek medical advice promptly. The accompanying documentary, available on the show’s social media channels, aims to deepen public knowledge and reduce the stigma surrounding ovarian cancer, potentially saving lives through greater awareness.